Exenatide improves postprandial hyperglycaemia and dyslipidaemia in metformin treated patients with type 2 diabetes

被引：0
|
作者：
Bunck, M. C. [1 ]
Corner, A. [2 ]
Diamant, M. [1 ]
Eliasson, B. [3 ]
Malloy, J. L. [4 ]
Shaginian, R. M. [5 ]
Deng, W. [4 ]
Kendall, D. M. [4 ]
Smith, U. [3 ]
Yki-Jarvinen, H. [2 ]
Heine, R. J. [1 ]
Taskinen, M. R. [2 ]
机构：
[1] Vrije Univ Amsterdam, Med Ctr, Ctr Diabet, Dept Endocrinol, Amsterdam, Netherlands
[2] Helsinki Univ Hosp, Dept Med, Helsinki, Finland
[3] Sahlgrens Univ Hosp, Lundberg Lab Diabet Res, Gothenburg, Sweden
[4] Amylin Pharmaceut Inc, San Diego, CA USA
[5] Eli Lilly & Co, Nederland, Houten, Netherlands
来源：
DIABETOLOGIA | 2008年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
879
引用
收藏
页码：S351 / S351
页数：1
相关论文
共 50 条
  • [21] Exenatide reduced body weight compared to insulin glargine in metformin and sulfonylurea-treated patients with type 2 diabetes
    Brodows, R
    Kim, D
    Burger, J
    Mihm, M
    Johns, D
    OBESITY RESEARCH, 2005, 13 : A132 - A132
  • [22] Effects of exenatide (exendin-4) on glycemic control and weight in patients with Type 2 diabetes treated with metformin and a sulfonylurea
    Kendall, DM
    Riddle, MC
    Zhuang, D
    Kim, DD
    Fineman, MS
    Baron, AD
    DIABETOLOGIA, 2004, 47 : A279 - A280
  • [23] Influence of postprandial hyperglycaemia on arterial function in patients with type 2 diabetes with or without albuminuria
    Saraheimo, M.
    Gordin, D.
    Soro-Paavonen, A.
    Forsblom, C.
    Paavonen, K.
    Steckel-Hamann, B.
    Vandenhende, F.
    Pavo, I.
    Koivisto, V.
    Groop, P. -H.
    DIABETOLOGIA, 2014, 57 : S527 - S527
  • [24] Exenatide therapy in insulin treated patients with type 2 diabetes and obesity
    Govindan, J. P.
    Healey, B.
    Kalupahana, D. N.
    Singh, B. M.
    DIABETOLOGIA, 2008, 51 : S352 - S353
  • [25] A Comparative Study on the Fasting and the Postprandial Dyslipidaemia in Type 2 Diabetes Mellitus
    Suryabhan, Lokhande L.
    Chandrashekhar, Iyer M.
    Ratnendra, Shinde R.
    Prerna, Nandedkar D.
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2013, 7 (04) : 627 - 630
  • [26] Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetes
    Cervera, Antonio
    Wajcberg, Estela
    Sriwijitkamol, Apiradee
    Fernandez, Marianella
    Zuo, Pengou
    Triplitt, Curtis
    Musi, Nicolas
    DeFronzo, Ralph A.
    Cersosimo, Eugenio
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2008, 294 (05): : E846 - E852
  • [27] Efficacy and safety of exenatide in patients of Asian descent with type 2 diabetes inadequately controlled with metformin or metformin and a sulphonylurea
    Gao, Yan
    Yoon, Kun Ho
    Chuang, Lee-Ming
    Mohan, Viswanathan
    Ning, Guang
    Shah, Sanjiv
    Jang, Hak Chul
    Wu, Ta-Jen
    Johns, Don
    Northrup, Justin
    Brodows, Robert
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2009, 83 (01) : 69 - 76
  • [28] Sustained Improvement of Postprandial Endothelial Function in Type 2 Diabetes With Exenatide
    Koska, Juraj
    Liu, James
    Raravikar, Kalyani
    Schwenke, Dawn C.
    Schwartz, Eric A.
    Reaven, Peter D.
    DIABETES, 2013, 62 : A311 - A311
  • [29] Effects of exenatide on gastric emptying and postprandial glucose in type 2 diabetes
    Linnebjerg, Helle
    Park, Soomin
    Kothare, Prajakti
    Trautmann, Michael
    Mace, Kenneth
    Fineman, Mark
    Wilding, Ian
    Nauck, Michael
    Horowitz, Michael
    DIABETES, 2006, 55 : A28 - A28
  • [30] Quantifying the effect of exenatide and insulin glargine on postprandial glucose excursions in patients with type 2 diabetes
    Brodows, Robert G.
    Qu, Yongming
    Johns, Don
    Kim, Dennis
    Holcombe, John H.
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (05) : 1395 - 1397
12345